Jean-Pierre Sommadossi
Chief Executive Officer at ATEA PHARMACEUTICALS, INC.
Net worth: 24 M $ as of 2024-03-30
Profile
Dr. Jean-Pierre Sommadossi is a Chairman at Kezar Life Sciences, Inc., a Chairman, President & Chief Executive Officer at Atea Pharmaceuticals, Inc., a Member-Discovery Council at Harvard Medical School and an Independent Director at ABG Acquisition Corp. I. He is on the Board of Directors at Rafael Pharmaceuticals, Inc., The BioExec Institute, Inc. and ABG Acquisition Corp. I. Dr. Sommadossi was previously employed as a Chairman, President & Chief Executive Officer by Idenix Pharmaceuticals LLC, a Co-Founder by Pharmasset, Inc., a Professor by The University of Alabama at Birmingham, a Fogarty Fellow by Medical College of Virginia, a Fogarty Fellow by National Cancer Institute, and an Advisor by Puretech Health LLC. He also served on the board at Alzheon, Inc. and Kinex Pharmaceuticals, Inc. He received his doctorate degree from the University of Marseille.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2024-01-31 | 6,041,557 ( 7.18% ) | 24 M $ | 2024-03-30 |
Jean-Pierre Sommadossi active positions
| Companies | Position | Start |
|---|---|---|
| ATEA PHARMACEUTICALS, INC. | Chief Executive Officer | 2012-11-30 |
| ABG ACQUISITION CORP. I | Director/Board Member | 2021-01-31 |
The BioExec Institute, Inc.
 The BioExec Institute, Inc. Miscellaneous Commercial ServicesCommercial Services The BioExec Institute, Inc. is a network of executives in the life sciences industry. The private company is based in Cambridge, MA. The company was founded in 2004 by Hoda Jeanne Abou-Jamra. Hoda Jeanne Abou-Jamra has been the CEO since 2004. | Director/Board Member | 2003-12-31 |
Biothea Pharma, Inc.
 Biothea Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services Biothea Pharma, Inc. is an American biotechnology company that operates in the field of pharmaceuticals. The private company was founded by John F. Vavricka. Marina S. Bozilenko has been the CEO of the company since 2021. | Chairman | 2014-12-31 |
Former positions of Jean-Pierre Sommadossi
| Companies | Position | End |
|---|---|---|
| KEZAR LIFE SCIENCES, INC. | Chairman | 2022-05-10 |
Pegaone GmbH
 Pegaone GmbH Information Technology ServicesTechnology Services Pegaone GmbH is a services and German solutions company that specializes in helping businesses transform and evolve digitally. The private company is based in Regensburg, Germany. The company achieves this by executing Pega implementations through proactive collaboration with their customers. | Chairman | 2020-12-31 |
| Harvard Medical School | Corporate Officer/Principal | 2020-12-31 |
Cornerstone Pharmaceuticals, Inc.
 Cornerstone Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Rafael Pharmaceuticals, Inc. develops anti-cancer drug delivery technology. It produces highly selective and effective anti-cancer agents with minimal toxic effects on normal cells and tissues by attacking regulatory processes that are unique to cancer and not found in healthy cells. The firm would ensure a significant improvement in the safety profile of cancer treatment. The firm provides CPI-613, Altered Energy Metabolism Directed (AEMD) platform, targets enzymes that are involved in cancer cell energy metabolism and are located in the mitochondria of cancer cells. The company was founded by Robert G. L. Shorr and is headquartered in Cranbury, NJ. | Director/Board Member | 2020-10-31 |
| ATHENEXPAR | Director/Board Member | 2014-06-30 |
Training of Jean-Pierre Sommadossi
| University of Marseille | Doctorate Degree |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| ATEA PHARMACEUTICALS, INC. | Health Technology |
| KEZAR LIFE SCIENCES, INC. | Health Technology |
| Private companies | 11 |
|---|---|
Cornerstone Pharmaceuticals, Inc.
Cornerstone Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Rafael Pharmaceuticals, Inc. develops anti-cancer drug delivery technology. It produces highly selective and effective anti-cancer agents with minimal toxic effects on normal cells and tissues by attacking regulatory processes that are unique to cancer and not found in healthy cells. The firm would ensure a significant improvement in the safety profile of cancer treatment. The firm provides CPI-613, Altered Energy Metabolism Directed (AEMD) platform, targets enzymes that are involved in cancer cell energy metabolism and are located in the mitochondria of cancer cells. The company was founded by Robert G. L. Shorr and is headquartered in Cranbury, NJ. | Commercial Services |
Idenix Pharmaceuticals LLC
 Idenix Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Idenix Pharmaceuticals LLC is a biopharmaceutical company, which is engaged in the discovery and development of drugs for the treatment of human viral diseases with operations in the United States and France. Currently, its primary research and development focus is on the treatment of patients with hepatitis C virus, or HCV, using nucleotide polymerase inhibitors and NS5A inhibitors. Idenix Pharmaceuticals was founded by Jean-Pierre Sommadossi and Raymond F. Schinazi in May 1998 and is headquartered in Cambridge, MA. | Health Technology |
Athenex, Inc.
 Athenex, Inc. Pharmaceuticals: MajorHealth Technology Athenex, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapies for the treatment of cancer. It operates through the Oncology Innovation Platform and Commercial Platform segments. The Oncology Innovation Platform segment focuses on the research and development of proprietary drugs. The Commercial Platform segment covers the sale and market of specialty drugs and market development of proprietary drugs. The company was founded by Lyn M. Dyster and David G. Hangauer in November 2003 and is headquartered in Buffalo, NY. | Health Technology |
Pharmasset, Inc.
 Pharmasset, Inc. Pharmaceuticals: OtherHealth Technology Pharmasset, Inc. developed drugs to treat viral infections. It focued in the development of oral therapeutics for the treatment of hepatitis C virus (HCV) infection. The company was founded in 1998 and was headquartered in Princeton, NJ. | Health Technology |
Alzheon, Inc.
 Alzheon, Inc. BiotechnologyHealth Technology Alzheon, Inc. engages in the provision of medical development. It specializes in treatment for brain health, memory, and aging. It offers ALZ-801, an oral small molecule inhibitor of amyloid formation and neurotoxicity with potential to be a therapy for a genetically defined population of patients with or at high risk for Alzheimer's disease and other neurodegenerative disorders. The company was founded by Martin Tolar in June 2013 and is headquartered in Framingham, MA. | Health Technology |
Puretech Health LLC
 Puretech Health LLC Investment ManagersFinance Puretech Health LLC (PureTech Ventures) is a venture capital subsidiary of PureTech Health Plc founded in 2000 by Daphne Zohar, Robert Langer and Ben Shapiro. The firm is headquartered in Boston, Massachusetts. | Finance |
National Cancer Institute
 National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD. | Miscellaneous |
The BioExec Institute, Inc.
The BioExec Institute, Inc. Miscellaneous Commercial ServicesCommercial Services The BioExec Institute, Inc. is a network of executives in the life sciences industry. The private company is based in Cambridge, MA. The company was founded in 2004 by Hoda Jeanne Abou-Jamra. Hoda Jeanne Abou-Jamra has been the CEO since 2004. | Commercial Services |
Pegaone GmbH
Pegaone GmbH Information Technology ServicesTechnology Services Pegaone GmbH is a services and German solutions company that specializes in helping businesses transform and evolve digitally. The private company is based in Regensburg, Germany. The company achieves this by executing Pega implementations through proactive collaboration with their customers. | Technology Services |
Biothea Pharma, Inc.
Biothea Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services Biothea Pharma, Inc. is an American biotechnology company that operates in the field of pharmaceuticals. The private company was founded by John F. Vavricka. Marina S. Bozilenko has been the CEO of the company since 2021. | Commercial Services |
ABG Acquisition Corp. I
 ABG Acquisition Corp. I Financial ConglomeratesFinance ABG Acquisition Corp. I is a blank check company. It was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more entities. The company was founded on November 17, 2020 and is headquartered in New York, NY. | Finance |
- Stock Market
- Insiders
- Jean-Pierre Sommadossi
